- £68.51bn
- £80.80bn
- £30.33bn
- 88
- 46
- 96
- 91
REG - GSK PLC - Statement: Zantac (ranitidine) litigation
AnnouncementREG - GSK PLC - GSK’s Arexvy recommended by ACIP
AnnouncementREG - GSK PLC - Season two data for GSK Arexvy RSV OA vaccine
AnnouncementREG - GSK PLC - Extension of FDA review period for momelotinib
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - EU authorisation of GSK’s RSV vaccine Arexvy
AnnouncementREG - GSK PLC - GSK receives US FDA file acceptance for Jemperli
AnnouncementREG - Allianz Glbl Inv - Top 10 Holdings
AnnouncementREG - GSK PLC - Total Voting Rights
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - Haleon PLC GSK PLC - Holding(s) in Company
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Block listing Interim Review
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - MenABCWY vaccine preliminary phase III results
AnnouncementREG - GSK PLC - Statement: Zantac Litigation Update BC Canada
AnnouncementREG - GSK PLC - GSK completes sale of shares in Haleon plc
AnnouncementREG - GSK PLC - GSK announces intention to sell shares in Haleon
AnnouncementREG - Allianz Glbl Inv - Top 10 Holdings
Announcement